Henry Esber Net Worth & Insider Trades

Henry Esber - Director, Innovus Pharmaceuticals, Inc

As of July 3, 2019

What is Henry Esber's Net Worth?

The current estimated net worth of Innovus Pharmaceuticals, Inc's Director, Henry Esber, is estimated to be about $2.69M . Henry Esber owns about 100,000 units of Innovus Pharmaceuticals, Inc common stock. In the last 4 years at Innovus Pharmaceuticals, Inc, Henry Esber has sold an estimated value of $0 worth.

What is Henry Esber's Past Insider Trading?

Henry Esber's largest purchase order was 100,000 units , worth over $9.29K on November 27, 2017. In total, Henry Esber has made about 22 transactions over 4 years of their time at Innovus Pharmaceuticals, Inc. Henry Esber usually trades in July and April, with the busiest year in 2015.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Henry Esber's' Mailing Address?

  • Mailing address is 38 Angell Brook Drive West Boylston MA 01853 MA

What are Innovus Pharmaceuticals, Inc's Past Insider Trades?

Innovus Pharmaceuticals, Inc's most recent insider trade came on July 18, 2023 by Nicole D'Amato who sold 5,866 units worth $41.67K . In the last 8 years, insiders at Innovus Pharmaceuticals, Inc have sold an estimated value of $694.23K and bought an estimated value of $1.4M worth of shares. Insider trading is most common in July, with the busiest year in 2023 and 2015. The most active traders at the company are Henry Esber, Director,  Ziad Mirza, Director,  and Vivian Liu, Director .

InnovAge Holding Corp. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...